L. E. Markowitz

717 total citations
16 papers, 532 citations indexed

About

L. E. Markowitz is a scholar working on Epidemiology, Health and Immunology. According to data from OpenAlex, L. E. Markowitz has authored 16 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 7 papers in Health and 7 papers in Immunology. Recurrent topics in L. E. Markowitz's work include Virology and Viral Diseases (8 papers), Immune responses and vaccinations (7 papers) and Vaccine Coverage and Hesitancy (7 papers). L. E. Markowitz is often cited by papers focused on Virology and Viral Diseases (8 papers), Immune responses and vaccinations (7 papers) and Vaccine Coverage and Hesitancy (7 papers). L. E. Markowitz collaborates with scholars based in United States, Thailand and Kenya. L. E. Markowitz's co-authors include Roland W. Sutter, Emmett B. Swint, Philip Rhodes, C Powell, Philipp Albrecht, William Atkinson, Akbar Zaidi, Adamadia Deforest, Elizabeth R. Zell and Gabriela Paz‐Bailey and has published in prestigious journals such as JAMA, PEDIATRICS and American Journal of Public Health.

In The Last Decade

L. E. Markowitz

16 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. E. Markowitz United States 13 374 227 167 141 77 16 532
N. A. Halsey United States 11 375 1.0× 135 0.6× 183 1.1× 77 0.5× 44 0.6× 13 517
Daoling Bi United States 13 647 1.7× 467 2.1× 285 1.7× 96 0.7× 19 0.2× 15 800
Peter Carrasco United States 13 470 1.3× 315 1.4× 244 1.5× 126 0.9× 21 0.3× 25 781
Carlos Castillo‐Solórzano United States 17 529 1.4× 268 1.2× 162 1.0× 74 0.5× 39 0.5× 30 655
Sari Jokinen Finland 9 532 1.4× 274 1.2× 284 1.7× 94 0.7× 31 0.4× 13 653
Sara Mercader United States 11 540 1.4× 303 1.3× 217 1.3× 171 1.2× 48 0.6× 22 642
Benjamin M. Nkowane Switzerland 9 148 0.4× 80 0.4× 220 1.3× 48 0.3× 16 0.2× 13 505
Emily Simons United States 11 489 1.3× 369 1.6× 183 1.1× 134 1.0× 17 0.2× 17 743
Elizabeth Rausch-Phung United States 8 328 0.9× 291 1.3× 134 0.8× 38 0.3× 20 0.3× 12 410
Peter Strebel United States 12 389 1.0× 295 1.3× 302 1.8× 171 1.2× 12 0.2× 16 724

Countries citing papers authored by L. E. Markowitz

Since Specialization
Citations

This map shows the geographic impact of L. E. Markowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. E. Markowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. E. Markowitz more than expected).

Fields of papers citing papers by L. E. Markowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. E. Markowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. E. Markowitz. The network helps show where L. E. Markowitz may publish in the future.

Co-authorship network of co-authors of L. E. Markowitz

This figure shows the co-authorship network connecting the top 25 collaborators of L. E. Markowitz. A scholar is included among the top collaborators of L. E. Markowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. E. Markowitz. L. E. Markowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vicari, Andrea, Shelley L. Deeks, Vesta Richardson López-Collada, et al.. (2011). Progress toward implementation of human papillomavirus vaccination - the Americas, 2006-2010.. MMWR Morbidity and Mortality Weekly Report. 60(40). 1382–1384. 38 indexed citations
2.
Cutts, FT, Silvia Franceschi, Xavier Castellsagué, et al.. (2007). Human Papillomavirus and HPV Vaccines: A review/Virus Du Papillome Humain et Vaccins Anti-VPH: bilan/Papilomavirus Humanos Y Vacunas Anti-PVH: Revision. Bulletin of the World Health Organization. 85(9). 719. 1 indexed citations
3.
Paz‐Bailey, Gabriela, Susan Blank, James Brown, et al.. (2004). A Case–Control Study of Syphilis Among Men Who Have Sex With Men in New York City. Sexually Transmitted Diseases. 31(10). 581–587. 77 indexed citations
4.
Markowitz, L. E., et al.. (1996). Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team.. PubMed. 97(1). 53–8. 80 indexed citations
5.
Gaywee, Jariyanart, Andrew W. Artenstein, Thomas C. VanCott, et al.. (1996). Correlation of Genetic and Serologic Approaches to HIV-1 Subtyping in Thailand. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 13(4). 392–396. 40 indexed citations
6.
Arpadi, Stephen M., L. E. Markowitz, Andrew L. Baughman, et al.. (1996). Measles Antibody in Vaccinated Human Immunodeficiency Virus Type 1-infected Children. PEDIATRICS. 97(5). 653–657. 58 indexed citations
7.
Aaby, Peter, Badara Samb, François Simondon, et al.. (1994). Sex-specific differences in mortality after high-titre measles immunization in rural Senegal.. PubMed. 72(5). 761–70. 64 indexed citations
8.
Cutts, Felicity T., et al.. (1994). Measles Control in Kinshasa, Zaire Improved with High Coverage and Use of Medium Titre Edmonston Zagreb Vaccine at Age 6 Months. International Journal of Epidemiology. 23(3). 624–631. 16 indexed citations
9.
Orenstein, Walter A., L. E. Markowitz, William Atkinson, & A. R. Hinman. (1994). Worldwide measles prevention.. PubMed. 30(5-6). 469–81. 12 indexed citations
10.
Strebel, Peter M., William Atkinson, L. E. Markowitz, et al.. (1993). Reporting efficiency during a measles outbreak in New York City, 1991.. American Journal of Public Health. 83(7). 1011–1015. 44 indexed citations
11.
Cutts, Felicity T., Michael St. Louis, Benjamin K. Mayala, et al.. (1993). Immunogenicity of High-Titer Edmonston-Zagreb Measles Vaccine in Human Immunodeficiency Virus-Infected Children in Kinshasa, Zaire. The Journal of Infectious Diseases. 167(6). 1418–1421. 20 indexed citations
12.
Markowitz, L. E., et al.. (1993). Response of human immunodeficiency virus-infected adults to measles-rubella vaccination.. PubMed. 6(9). 1013–6. 27 indexed citations
13.
Sutter, Roland W., et al.. (1991). Measles among the Amish: A Comparative Study of Measles Severity in Primary and Secondary Cases in Households. The Journal of Infectious Diseases. 163(1). 12–16. 34 indexed citations
14.
Markowitz, L. E., et al.. (1987). Measles hospitalizations, United States, 1977-84: comparison with national surveillance data.. American Journal of Public Health. 77(7). 866–868. 13 indexed citations
15.
Markowitz, L. E.. (1987). Toxic shock syndrome. Evaluation of national surveillance data using a hospital discharge survey. JAMA. 258(1). 75–78. 7 indexed citations
16.
Markowitz, L. E.. (1986). TICK-BORNE TULAREMIA. The Pediatric Infectious Disease Journal. 5(4). 501–501. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026